Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
thiotepa
i
Other names:
DSP-1958
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Generic mfg.
Drug class:
DNA synthesis inhibitor, Alkylating agent
Related drugs:
‹
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
procarbazine hydrochloride (4)
OBI-3424 (4)
D19466 (4)
bendamustine RTD (2)
LP-284 (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
procarbazine hydrochloride (4)
OBI-3424 (4)
D19466 (4)
bendamustine RTD (2)
LP-284 (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Lymphoma
No biomarker
Lymphoma
cytarabine + thiotepa
Sensitive: A2 - Guideline
cytarabine + thiotepa
Sensitive
:
A2
cytarabine + thiotepa
Sensitive: A2 - Guideline
cytarabine + thiotepa
Sensitive
:
A2
No biomarker
Lymphoma
No biomarker
Lymphoma
cytarabine + methotrexate + thiotepa
Sensitive: A2 - Guideline
cytarabine + methotrexate + thiotepa
Sensitive
:
A2
cytarabine + methotrexate + thiotepa
Sensitive: A2 - Guideline
cytarabine + methotrexate + thiotepa
Sensitive
:
A2
ER positive
HER2 Negative Breast Cancer
ER positive
HER2 Negative Breast Cancer
cyclophosphamide + thiotepa
Sensitive: B - Late Trials
cyclophosphamide + thiotepa
Sensitive
:
B
cyclophosphamide + thiotepa
Sensitive: B - Late Trials
cyclophosphamide + thiotepa
Sensitive
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.